HDAC8 has been recently reported to promote insulin resistance and activate Wnt/β-catenin pathway in a NAFLD-HCC mouse model treated with high fat high carbohydrate diet. This evidence concerns the gene HDAC8 and metabolic dysfunction-associated steatotic liver disease.